These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

354 related items for PubMed ID: 24475864

  • 1. Respiratory motion artifact affecting hepatic arterial phase imaging with gadoxetate disodium: examination recovery with a multiple arterial phase acquisition.
    Pietryga JA, Burke LM, Marin D, Jaffe TA, Bashir MR.
    Radiology; 2014 May; 271(2):426-34. PubMed ID: 24475864
    [Abstract] [Full Text] [Related]

  • 2. Matched within-patient cohort study of transient arterial phase respiratory motion-related artifact in MR imaging of the liver: gadoxetate disodium versus gadobenate dimeglumine.
    Davenport MS, Caoili EM, Kaza RK, Hussain HK.
    Radiology; 2014 Jul; 272(1):123-31. PubMed ID: 24617733
    [Abstract] [Full Text] [Related]

  • 3. Respiratory motion artifact affecting hepatic arterial phase MR imaging with gadoxetate disodium is more common in patients with a prior episode of arterial phase motion associated with gadoxetate disodium.
    Bashir MR, Castelli P, Davenport MS, Larson D, Marin D, Hussain HK, Jaffe TA.
    Radiology; 2015 Jan; 274(1):141-8. PubMed ID: 25162310
    [Abstract] [Full Text] [Related]

  • 4. Comparison of acute transient dyspnea after intravenous administration of gadoxetate disodium and gadobenate dimeglumine: effect on arterial phase image quality.
    Davenport MS, Viglianti BL, Al-Hawary MM, Caoili EM, Kaza RK, Liu PS, Maturen KE, Chenevert TL, Hussain HK.
    Radiology; 2013 Feb; 266(2):452-61. PubMed ID: 23192781
    [Abstract] [Full Text] [Related]

  • 5. Transient Severe Motion Artifact Related to Gadoxetate Disodium-Enhanced Liver MRI: Frequency and Risk Evaluation at a German Institution.
    Well L, Rausch VH, Adam G, Henes FO, Bannas P.
    Rofo; 2017 Jul; 189(7):651-660. PubMed ID: 28445909
    [Abstract] [Full Text] [Related]

  • 6. Diagnosis of focal nodular hyperplasia with MRI: multicenter retrospective study comparing gadobenate dimeglumine to gadoxetate disodium.
    Gupta RT, Iseman CM, Leyendecker JR, Shyknevsky I, Merkle EM, Taouli B.
    AJR Am J Roentgenol; 2012 Jul; 199(1):35-43. PubMed ID: 22733891
    [Abstract] [Full Text] [Related]

  • 7. Intravenous Gadoxetate Disodium Administration Reduces Breath-holding Capacity in the Hepatic Arterial Phase: A Multi-Center Randomized Placebo-controlled Trial.
    McClellan TR, Motosugi U, Middleton MS, Allen BC, Jaffe TA, Miller CM, Reeder SB, Sirlin CB, Bashir MR.
    Radiology; 2017 Feb; 282(2):361-368. PubMed ID: 27509544
    [Abstract] [Full Text] [Related]

  • 8. Influence of Gadoxetate Disodium on Oxygen Saturation and Heart Rate during Dynamic Contrast-enhanced MR Imaging.
    Hayashi T, Saitoh S, Tsuji Y, Takahashi J, Tagaya N, Hiramoto M, Fukuzawa K, Tano M, Miyati T, Kumada H.
    Radiology; 2015 Sep; 276(3):756-65. PubMed ID: 25811243
    [Abstract] [Full Text] [Related]

  • 9. Respiratory-motion artefacts in liver MRI following injection of gadoxetate disodium and gadobenate dimeglumine: an intra-individual comparative study in cirrhotic patients.
    Furlan A, Close ON, Borhani AA, Wu YH, Heller MT.
    Clin Radiol; 2017 Jan; 72(1):93.e1-93.e6. PubMed ID: 27633725
    [Abstract] [Full Text] [Related]

  • 10. Hepatic hemangiomas: difference in enhancement pattern on 3T MR imaging with gadobenate dimeglumine versus gadoxetate disodium.
    Gupta RT, Marin D, Boll DT, Husarik DB, Davis DE, Feuerlein S, Merkle EM.
    Eur J Radiol; 2012 Oct; 81(10):2457-62. PubMed ID: 22138122
    [Abstract] [Full Text] [Related]

  • 11. Transient respiratory motion artifacts in multiple arterial phases on abdominal dynamic magnetic resonance imaging: a comparison using gadoxetate disodium and gadobutrol.
    Tanabe M, Higashi M, Iida E, Onoda H, Ihara K, Ariyoshi S, Kameda F, Miyoshi K, Furukawa M, Okada M, Ito K.
    Jpn J Radiol; 2021 Feb; 39(2):178-185. PubMed ID: 32959222
    [Abstract] [Full Text] [Related]

  • 12. Biologic factors affecting HCC conspicuity in hepatobiliary phase imaging with liver-specific contrast agents.
    Kim JY, Lee SS, Byun JH, Kim SY, Park SH, Shin YM, Lee MG.
    AJR Am J Roentgenol; 2013 Aug; 201(2):322-31. PubMed ID: 23883212
    [Abstract] [Full Text] [Related]

  • 13. Evaluation of incidence of acute transient dyspnea and related artifacts after administration of gadoxetate disodium: a prospective observational study.
    Grazioli L, Faletti R, Frittoli B, Battisti G, Ambrosini R, Romanini L, Gatti M, Fonio P.
    Radiol Med; 2018 Dec; 123(12):910-917. PubMed ID: 30084108
    [Abstract] [Full Text] [Related]

  • 14. Respiratory motion in children and young adults undergoing liver magnetic resonance imaging with intravenous gadoxetate disodium contrast material.
    Gilligan LA, Trout AT, Anton CG, Schapiro AH, Towbin AJ, Dillman JR.
    Pediatr Radiol; 2019 Aug; 49(9):1171-1176. PubMed ID: 31203405
    [Abstract] [Full Text] [Related]

  • 15. Respiratory-triggered three-dimensional T2-weighted MR cholangiography after injection of gadoxetate disodium: is it still reliable?
    Ringe KI, Gupta RT, Brady CM, Massey CM, Hahn A, Galanski M, Merkle EM, Lotz J.
    Radiology; 2010 May; 255(2):451-8. PubMed ID: 20413758
    [Abstract] [Full Text] [Related]

  • 16. Transient severe motion in the arterial phase during gadoxetate disodium-enhanced MR imaging: evaluation of patients with multiple MR examinations.
    Im WH, Song JS, Park EH, Kwak HS.
    Abdom Radiol (NY); 2017 Oct; 42(10):2393-2401. PubMed ID: 28396919
    [Abstract] [Full Text] [Related]

  • 17. Respiratory motion artefacts in dynamic liver MRI: a comparison using gadoxetate disodium and gadobutrol.
    Luetkens JA, Kupczyk PA, Doerner J, Fimmers R, Willinek WA, Schild HH, Kukuk GM.
    Eur Radiol; 2015 Nov; 25(11):3207-13. PubMed ID: 25903709
    [Abstract] [Full Text] [Related]

  • 18. Transient respiratory motion artifact during arterial phase MRI with gadoxetate disodium: risk factor analyses.
    Kim SY, Park SH, Wu EH, Wang ZJ, Hope TA, Chang WC, Yeh BM.
    AJR Am J Roentgenol; 2015 Jun; 204(6):1220-7. PubMed ID: 26001231
    [Abstract] [Full Text] [Related]

  • 19. Comparison of Visualization Rates of LI-RADS Version 2014 Major Features With IV Gadobenate Dimeglumine or Gadoxetate Disodium in Patients at Risk for Hepatocellular Carcinoma.
    Allen BC, Ho LM, Jaffe TA, Miller CM, Mazurowski MA, Bashir MR.
    AJR Am J Roentgenol; 2018 Jun; 210(6):1266-1272. PubMed ID: 29629800
    [Abstract] [Full Text] [Related]

  • 20. Comparison of transient severe motion in gadoxetate disodium and gadopentetate dimeglumine-enhanced MRI: effect of modified breath-holding method.
    Song JS, Choi EJ, Park EH, Lee JH.
    Eur Radiol; 2018 Mar; 28(3):1132-1139. PubMed ID: 28986630
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.